SAN DIEGO,  look  CA.—Acutus Medical announced the issuance of U.S. Patent number 8,  click  417, 313 which relates to the method and device for determining and presenting surface charge and dipole density on cardiac walls. This patent focuses on an innovative method in cardiac electrophysiology

Three years ago,  malady  the FDA approved Johnson & Johnson’s thermocool, the first in a series of ablation catheters specifically designed to halt atrial fibrillation. Despite these advances, the long-term success rates of catheter ablation procedures remain low, opening the door for start-ups to

—Funds and team growth for developing a breakthrough medical system for mapping of atrial fibrillation— 20th January 2012, London: – Advent Life Sciences announced it has invested $2.2 million in Acutus Medical, a medical technology company based in San Diego and Zurich, as part of a Series A of

New medical technology company focused on developing a breakthrough device for real time mapping of Atrial Fibrillation 8th August 2011, San Diego, USA:  – Index Ventures, together with private investors, has invested an initial funding of $1 million in Acutus Medical, a newly founded medical